tert-Butyl isoindoline-2-carboxylate

Catalog No.: 
ACPOSD023
CAS No.: 
260412-75-7
Molecular Formula: 
C13H17NO2
Molecular Weight: 
219.28
tert-Butyl isoindoline-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$165.00InquiryInquiry
1g96%$370.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl isoindoline-2-carboxylate
IUPAC Nametert-butyl isoindoline-2-carboxylate
MDL No.MFCD21106377
Molecular FormulaC13H17NO2
Molecular Weight219.28
SMILESO=C(N1CC2=C(C=CC=C2)C1)OC(C)(C)C
InChI KeyDXECVLLAHDLREE-UHFFFAOYSA-N
Synonymt-Butyl 1,3-dihydroisoindole-2-carboxylate;1,3-Dihydro-isoindole-2-carboxylic acid tert-butyl ester;tert-Butyl isoindoline-2-carboxylate;2H-Isoindole-2-carboxylic acid, 1,3-dihydro-, 1,1-dimethylethyl ester;tert-Butyl 1,3-Dihydroisoindole-2-carboxylate
CAS No.260412-75-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPOSD023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRDAJ357 route compound structure diagram
    ACRDAJ357496-12-8In Stock
  4. Then
  5. ACPOSD023 route product structure diagram
    ACPOSD023260412-75-7
Inquiry

2. ACPOSD023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVTU012 route compound structure diagram
    ACQVTU0121333114-86-5In Stock
  2. Then
  3. ACPOSD023 route product structure diagram
    ACPOSD023260412-75-7
Inquiry

3. ACPOSD023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPOSD023 route product structure diagram
    ACPOSD023260412-75-7
Inquiry

Comments (0)